232 related articles for article (PubMed ID: 28287942)
1. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.
Lakhani A; Khan SR; Bharwani N; Stewart V; Rockall AG; Khan S; Barwick TD
Radiographics; 2017; 37(2):577-594. PubMed ID: 28287942
[TBL] [Abstract][Full Text] [Related]
2. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
Yu JQ; Doss M; Alpaugh RK
PET Clin; 2018 Apr; 13(2):249-268. PubMed ID: 29482753
[TBL] [Abstract][Full Text] [Related]
5. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
6. Gynecologic oncologic imaging with PET/CT.
Grant P; Sakellis C; Jacene HA
Semin Nucl Med; 2014; 44(6):461-78. PubMed ID: 25362236
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
Gorospe L; Jover-Díaz R; Vicente-Bártulos A
Abdom Imaging; 2012 Dec; 37(6):1041-65. PubMed ID: 22349805
[TBL] [Abstract][Full Text] [Related]
8. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
9. Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET.
Subhas N; Patel PV; Pannu HK; Jacene HA; Fishman EK; Wahl RL
Radiographics; 2005; 25(4):1031-43. PubMed ID: 16009822
[TBL] [Abstract][Full Text] [Related]
10. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.
Shreve PD; Anzai Y; Wahl RL
Radiographics; 1999; 19(1):61-77; quiz 150-1. PubMed ID: 9925392
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary involvement of lymphomas on FDG-PET.
Naik N; Lin M; Lin P
Br J Radiol; 2018 Jun; 91(1086):20170273. PubMed ID: 29322833
[TBL] [Abstract][Full Text] [Related]
13. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
14. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
15. Pitfalls in Interpretation of PET/CT in the Chest.
Strange C; Shroff GS; Truong MT; Rohren EM
Semin Ultrasound CT MR; 2021 Dec; 42(6):588-598. PubMed ID: 34895614
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Assessment of Gynecologic Malignancies.
Tripathy S; Parida GK; Kumar R
PET Clin; 2018 Apr; 13(2):269-288. PubMed ID: 29482754
[No Abstract] [Full Text] [Related]
17. Pitfalls in [¹⁸F]FDG PET imaging in gynecological malignancies.
Hernandez Pampaloni M; Facchetti L; Nardo L
Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):124-38. PubMed ID: 26937887
[TBL] [Abstract][Full Text] [Related]
18. F18-FDG coincidence-PET in patients with suspected gynecological malignancy.
Zor E; Stokkel MP; Ozalp S; Vardareli E; Yalçin OT; Ak I
Acta Radiol; 2006 Jul; 47(6):612-7. PubMed ID: 16875342
[TBL] [Abstract][Full Text] [Related]
19. The role of FDG-PET/CT in gynaecological cancers.
Rockall AG; Cross S; Flanagan S; Moore E; Avril N
Cancer Imaging; 2012 Mar; 12(1):49-65. PubMed ID: 22391444
[TBL] [Abstract][Full Text] [Related]
20. PET/CT Limitations and Pitfalls in Urogenital Cancers.
Vasireddi A; Nguyen NC
Semin Nucl Med; 2021 Nov; 51(6):611-620. PubMed ID: 34243903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
